Opinion
Video
Experts discuss how payer and reimbursement considerations affect access to bispecific therapies in different practice settings.
Video content above is prompted by the following:
How do payer and reimbursement considerations affect access to bispecific therapies in different practice settings?
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.